The Russell 2000’s Blistering Start to 2026
US small-cap stocks have opened 2026 with their strongest first half in more than three decades. The Russell 2000 index surged roughly 22%, outperforming many large-cap benchmarks and marking its best H1 since 1991. The rally has been broad, but it has drawn extra fuel from the boom in artificial intelligence infrastructure — semiconductor makers and component suppliers account for 16 of the top 50 performers in the index, with some names leaping more than 400% year-to-date.
Goldman Sachs Asset Management, in its mid-year investment outlook, argues that the advance is not a classic bubble but a long-overdue recovery. For years, smaller companies lagged as Big Tech dominated markets. Now a mix of stronger earnings, attractive valuations relative to large caps, and a modest uptick in US economic activity is helping small caps close that gap. “It’s both a valuation catch-up and a fundamental development,” Alger fund manager Amy Zhang told CNBC, adding that the prior valuation gap was so wide “you could drive a truck through it.”
The numbers bear that out. Earnings growth expectations for Russell 2000 companies in 2026 have jumped from about 23% to 38%, according to LPL Financial. Merger-and-acquisition activity, especially in pharma and biotech, and potential tax incentives for investment are providing additional support. Yet the wildcard is interest rates: smaller companies frequently rely on variable-rate debt and must refinance more often. If financing costs climb further, their profits will be squeezed before the recovery can fully take hold.
Why Goldman Sachs Calls This a Recovery, Not a Bubble
A Recovery, Not a Bubble — The Goldman Argument
Goldman Sachs points to three pillars supporting the rally: an improving earnings outlook, cyclically low valuations, and an economy that is still expanding. The upgrade in Russell 2000 profit forecasts from 23% to 38% is a concrete sign of real business momentum, not just speculative fever. While some individual semiconductor and AI-related names have delivered eye-watering returns, the firm sees the broader move as a rational recalibration after years in which small caps traded at a deep discount to their larger peers.
The Semiconductor and AI Infrastructure Windfall
The rally has a concentrated engine. Sixteen of the Russell 2000’s top 50 performers are in the semiconductor and equipment supply chain, riding the massive build-out of AI data centres. That backbone is powerful but also creates a dependency: if AI-related capital spending slows, a large chunk of the index’s leadership could stall. Still, Goldman and others hope the earnings uplift will spread to non-tech sectors, a crucial test for the rally’s durability.
The Rate-Sensitivity Trap
Interest rate risk is the main threat to the optimistic narrative. Small caps often hold floating-rate debt and need frequent refinancing, making them acutely sensitive to even modest increases in benchmark rates. If the Federal Reserve keeps policy tighter for longer than expected, profit margins could erode, potentially reversing the earnings revisions that have drawn investors in. Zhang told CNBC she believes the economy is “probably near the peak in inflation and rates,” but that remains an assumption, not a guarantee.
What the Small-Cap Rally Means for Investors
- Monitor the earnings-revision trajectory. The jump from 23% to 38% is a powerful signal, but whether it holds—and whether upgrades spread beyond the semiconductor cluster—will determine how long this rally can last.
- Watch the rate data. A renewed rise in yields could quickly puncture small-cap momentum because of their heavy reliance on variable-rate borrowing and refinancing. Even near-peak rates would only help if they fall soon.
- Note the concentration risk. Over 400% gains in a handful of semiconductor names show where the biggest bets have paid off, but they also highlight how much the index’s recent strength depends on a single theme.
- M&A in pharma and biotech is a secondary tailwind. While not directly linked to the AI surge, a pickup in dealmaking could provide a cushion if the tech-led momentum fades.
Risk & Opportunity Assessment
| Commercial Risk | High | Small-cap companies are more exposed to variable-rate debt and refinancing needs; rising borrowing costs could compress margins and undercut the earnings recovery that justifies current valuations. |
| Competitive Risk | Medium | If the US economic rebound stalls, large caps with stronger balance sheets and steadier cash flows could regain investor preference, limiting the small-cap outperformance. |
| Regulatory Risk | Low | No significant new regulatory threats highlighted in the story, though tax incentive changes remain a potential variable. |
| Reputation Risk | Low | No reputational crises affecting the small-cap universe are indicated. |
| Technology Disruption | Low | The rally is partially fuelled by AI infrastructure spending, a positive disruption for small-cap semis; however, a sudden slowdown in that capex cycle would hit the index’s best performers disproportionately. |
| Commercial Opportunity | High | Earnings growth forecasts have nearly doubled, and M&A activity in pharma/biotech plus tax investment incentives could extend the rally well beyond the semiconductor niche. |
Comments 0